NCT05006443View on ClinicalTrials.gov

Staging Classification of Severe Tricuspid Regurgitation Using Novel Cardiac Imaging Techniques

NACompletedINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

January 14, 2022

Primary Completion Date

December 12, 2023

Study Completion Date

April 30, 2025

Conditions
Tricuspid Regurgitation
Interventions
DIAGNOSTIC_TEST

Cardiac Magnetic Resonance

a non-invasive assessment to determine severity of tricuspid regurgitation

Trial Locations (1)

55905

Mayo Clinic, Rochester

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
lead

Mayo Clinic

OTHER

NCT05006443 - Staging Classification of Severe Tricuspid Regurgitation Using Novel Cardiac Imaging Techniques | Biotech Hunter | Biotech Hunter